

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.73739868 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.43676350 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.12325470 |
| 4 | presynaptic membrane organization (GO:0097090) | 4.85597085 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 4.70582903 |
| 6 | central nervous system myelination (GO:0022010) | 4.70582903 |
| 7 | response to peptidoglycan (GO:0032494) | 4.47131127 |
| 8 | vocalization behavior (GO:0071625) | 4.37292933 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.36042598 |
| 10 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.24495025 |
| 11 | short-term memory (GO:0007614) | 4.22998270 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.20908922 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.05739729 |
| 14 | positive regulation of synapse assembly (GO:0051965) | 4.04349762 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.03820140 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02027322 |
| 17 | postsynaptic membrane organization (GO:0001941) | 4.00569540 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.00234870 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.98970709 |
| 20 | regulation of podosome assembly (GO:0071801) | 3.98710367 |
| 21 | neuron recognition (GO:0008038) | 3.95228358 |
| 22 | protein localization to synapse (GO:0035418) | 3.90805493 |
| 23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.89885690 |
| 24 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.86426375 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.85380021 |
| 26 | regulation of pigment cell differentiation (GO:0050932) | 3.84493044 |
| 27 | ATP synthesis coupled proton transport (GO:0015986) | 3.82712062 |
| 28 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.82712062 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 3.81081675 |
| 30 | regulation of vitamin metabolic process (GO:0030656) | 3.79332977 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78974558 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.78974558 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.74901999 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.72669924 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64823945 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.64823945 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64823945 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64823945 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64823945 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.64823945 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.62102476 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.62102476 |
| 43 | neuron remodeling (GO:0016322) | 3.58556124 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.57305665 |
| 45 | response to type I interferon (GO:0034340) | 3.57276111 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55289210 |
| 47 | regulation of mononuclear cell migration (GO:0071675) | 3.54711020 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51567798 |
| 49 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.50802299 |
| 50 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.50670438 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.48696344 |
| 52 | negative regulation of neurotransmitter transport (GO:0051589) | 3.47370416 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.46331436 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.46022138 |
| 55 | angiotensin maturation (GO:0002003) | 3.45172646 |
| 56 | T-helper 1 type immune response (GO:0042088) | 3.43493159 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.43219799 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 3.43079787 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41600433 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 3.39284847 |
| 61 | microglial cell activation (GO:0001774) | 3.38973935 |
| 62 | response to histamine (GO:0034776) | 3.37982541 |
| 63 | positive regulation of heat generation (GO:0031652) | 3.36955220 |
| 64 | cranial nerve morphogenesis (GO:0021602) | 3.36096764 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.35946722 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35321945 |
| 67 | regulation of chronic inflammatory response (GO:0002676) | 3.34073421 |
| 68 | defense response to protozoan (GO:0042832) | 3.32701782 |
| 69 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.26706479 |
| 70 | protein neddylation (GO:0045116) | 3.26204592 |
| 71 | neuronal ion channel clustering (GO:0045161) | 3.24754491 |
| 72 | limb bud formation (GO:0060174) | 3.23189382 |
| 73 | detection of other organism (GO:0098543) | 3.23187897 |
| 74 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.22806104 |
| 75 | regulation of dendritic spine development (GO:0060998) | 3.21954340 |
| 76 | righting reflex (GO:0060013) | 3.21515579 |
| 77 | response to protozoan (GO:0001562) | 3.19764837 |
| 78 | granulocyte activation (GO:0036230) | 3.19271948 |
| 79 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.18887932 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 3.18556109 |
| 81 | regulation of chemokine biosynthetic process (GO:0045073) | 3.17224055 |
| 82 | regulation of interleukin-12 production (GO:0032655) | 3.16773657 |
| 83 | macrophage activation (GO:0042116) | 3.15524986 |
| 84 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.14907940 |
| 85 | regulation of synapse assembly (GO:0051963) | 3.14608278 |
| 86 | regulation of fever generation (GO:0031620) | 3.13098557 |
| 87 | axonal fasciculation (GO:0007413) | 3.13079121 |
| 88 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.12373648 |
| 89 | positive regulation of type 2 immune response (GO:0002830) | 3.11967594 |
| 90 | glycolipid catabolic process (GO:0019377) | 3.09335770 |
| 91 | B cell mediated immunity (GO:0019724) | 3.09152868 |
| 92 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.08576286 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.08472036 |
| 94 | myeloid dendritic cell differentiation (GO:0043011) | 3.07787311 |
| 95 | synaptic transmission, glutamatergic (GO:0035249) | 3.07085294 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 3.06850447 |
| 97 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.05338432 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05253726 |
| 99 | detection of bacterium (GO:0016045) | 3.04194509 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.03939567 |
| 101 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.02228064 |
| 102 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.01737293 |
| 103 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99810901 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96437050 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.95071023 |
| 106 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.93956246 |
| 107 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.93956246 |
| 108 | GTP biosynthetic process (GO:0006183) | 2.93528589 |
| 109 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93260503 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92497868 |
| 111 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91944373 |
| 112 | germinal center formation (GO:0002467) | 2.91660097 |
| 113 | oligosaccharide catabolic process (GO:0009313) | 2.90590340 |
| 114 | positive regulation of membrane potential (GO:0045838) | 2.90500993 |
| 115 | respiratory electron transport chain (GO:0022904) | 2.90261140 |
| 116 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89926129 |
| 117 | regulation of cholesterol esterification (GO:0010872) | 2.89635325 |
| 118 | ensheathment of neurons (GO:0007272) | 2.88780907 |
| 119 | axon ensheathment (GO:0008366) | 2.88780907 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88177913 |
| 121 | regulation of T cell tolerance induction (GO:0002664) | 2.87998621 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.87856850 |
| 123 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.87844493 |
| 124 | membrane hyperpolarization (GO:0060081) | 2.87488887 |
| 125 | neutrophil activation (GO:0042119) | 2.87270378 |
| 126 | synaptic vesicle exocytosis (GO:0016079) | 2.86836406 |
| 127 | myelination (GO:0042552) | 2.86479411 |
| 128 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.84901442 |
| 129 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.84711960 |
| 130 | monocyte chemotaxis (GO:0002548) | 2.84129833 |
| 131 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.83910795 |
| 132 | ceramide catabolic process (GO:0046514) | 2.83585064 |
| 133 | nucleobase catabolic process (GO:0046113) | 2.82302909 |
| 134 | mating behavior (GO:0007617) | 2.81356460 |
| 135 | cellular response to interferon-gamma (GO:0071346) | 2.80242918 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79771506 |
| 137 | sialylation (GO:0097503) | 2.79666787 |
| 138 | electron transport chain (GO:0022900) | 2.79219570 |
| 139 | myeloid dendritic cell activation (GO:0001773) | 2.78887629 |
| 140 | oligodendrocyte differentiation (GO:0048709) | 2.78062671 |
| 141 | regulation of dopamine metabolic process (GO:0042053) | 2.77985344 |
| 142 | regulation of catecholamine metabolic process (GO:0042069) | 2.77985344 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77704544 |
| 144 | eosinophil chemotaxis (GO:0048245) | 2.76958062 |
| 145 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.75979891 |
| 146 | long-term memory (GO:0007616) | 2.74861299 |
| 147 | virion attachment to host cell (GO:0019062) | 2.74780061 |
| 148 | adhesion of symbiont to host cell (GO:0044650) | 2.74780061 |
| 149 | adult walking behavior (GO:0007628) | 2.74557702 |
| 150 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.73333885 |
| 151 | forebrain neuron development (GO:0021884) | 2.72503762 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72273996 |
| 153 | regulation of heat generation (GO:0031650) | 2.71829728 |
| 154 | positive regulation of interferon-beta production (GO:0032728) | 2.71041226 |
| 155 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.70342874 |
| 156 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70005751 |
| 157 | response to interferon-gamma (GO:0034341) | 2.69998582 |
| 158 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.69573144 |
| 159 | detection of external biotic stimulus (GO:0098581) | 2.68838339 |
| 160 | negative regulation of growth of symbiont in host (GO:0044130) | 2.68788194 |
| 161 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68788194 |
| 162 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.68788194 |
| 163 | regulation of growth of symbiont in host (GO:0044126) | 2.68788194 |
| 164 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.67852565 |
| 165 | startle response (GO:0001964) | 2.67617818 |
| 166 | detection of molecule of bacterial origin (GO:0032490) | 2.65853340 |
| 167 | reactive oxygen species biosynthetic process (GO:1903409) | 2.65371320 |
| 168 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.64984847 |
| 169 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.64800924 |
| 170 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.63799762 |
| 171 | positive regulation of interleukin-12 production (GO:0032735) | 2.63078804 |
| 172 | respiratory burst (GO:0045730) | 2.62908762 |
| 173 | retina layer formation (GO:0010842) | 2.62456821 |
| 174 | positive regulation of action potential (GO:0045760) | 2.61914232 |
| 175 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61337082 |
| 176 | regulation of postsynaptic membrane potential (GO:0060078) | 2.60490022 |
| 177 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.58948194 |
| 178 | synaptic transmission, dopaminergic (GO:0001963) | 2.58838738 |
| 179 | nonmotile primary cilium assembly (GO:0035058) | 2.57719369 |
| 180 | regulation of glutamate secretion (GO:0014048) | 2.57173350 |
| 181 | developmental pigmentation (GO:0048066) | 2.56245994 |
| 182 | synapse assembly (GO:0007416) | 2.54736312 |
| 183 | regulation of vesicle fusion (GO:0031338) | 2.54445721 |
| 184 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.54009328 |
| 185 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.53113795 |
| 186 | spinal cord development (GO:0021510) | 2.51584411 |
| 187 | dendrite development (GO:0016358) | 2.51107406 |
| 188 | lymphoid progenitor cell differentiation (GO:0002320) | 2.51042245 |
| 189 | layer formation in cerebral cortex (GO:0021819) | 2.49600654 |
| 190 | cellular response to epinephrine stimulus (GO:0071872) | 2.48944908 |
| 191 | adult feeding behavior (GO:0008343) | 2.48257600 |
| 192 | substantia nigra development (GO:0021762) | 2.47896371 |
| 193 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.46384437 |
| 194 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.46353279 |
| 195 | regulation of synapse organization (GO:0050807) | 2.46010561 |
| 196 | DNA damage response, detection of DNA damage (GO:0042769) | 2.44719575 |
| 197 | behavioral defense response (GO:0002209) | 2.43587081 |
| 198 | behavioral fear response (GO:0001662) | 2.43587081 |
| 199 | L-fucose metabolic process (GO:0042354) | 2.43033857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.03374555 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.75516839 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44214823 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.55233378 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83107049 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.68400920 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.52972513 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.24045847 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22311239 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.21910936 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.08459074 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06412207 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95991610 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.89682645 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89458259 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.87897939 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72007933 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67921360 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67921360 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.65647143 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62817700 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60092507 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60064161 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.56889420 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53268077 |
| 26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50495086 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.38854610 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38741334 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.38617328 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31497361 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.31243482 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29522438 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25180030 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.21340772 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.19028819 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 2.16193359 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15957915 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13162680 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10450149 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09128143 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06424767 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04870424 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01158783 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99546803 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.97778682 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.97575315 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97248415 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92576215 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92408025 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91777970 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88246802 |
| 52 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85426072 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85021613 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84429393 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84177217 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82960144 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82947122 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74050752 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.72531880 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.72495025 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67727425 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67250794 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67072493 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.65661079 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65182624 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64076401 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59683019 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58318896 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57984362 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57214570 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.55873385 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55165750 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54960212 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54471034 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53970434 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52643710 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51106993 |
| 78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48529847 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.45201989 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44766207 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44705272 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44168038 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43850121 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42493296 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41381767 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38192193 |
| 87 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.37628838 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37528967 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37432837 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36502334 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33946060 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.33665178 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33037912 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31124573 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30093148 |
| 96 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28075833 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27931913 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27770161 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27688751 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27065736 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26886636 |
| 102 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26083548 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23979561 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23413067 |
| 105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22762537 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22364898 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21806083 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20632534 |
| 109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.20431930 |
| 110 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19668305 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19316679 |
| 112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17520118 |
| 113 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17285032 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14176445 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13973448 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13752840 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12336652 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11397314 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11289849 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10934320 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09499677 |
| 122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09281088 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 1.09023715 |
| 124 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08073292 |
| 125 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07931789 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07640626 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07471657 |
| 128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04083925 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03532469 |
| 130 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03479056 |
| 131 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03178917 |
| 132 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02553866 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02553866 |
| 134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01472686 |
| 135 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01206109 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00988664 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00390033 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99966410 |
| 139 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99006769 |
| 140 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98623348 |
| 141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98471958 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98262671 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97011251 |
| 144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96132546 |
| 145 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95967633 |
| 146 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95749883 |
| 147 | JUN_21703547_ChIP-Seq_K562_Human | 0.95629180 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95191440 |
| 149 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94629968 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94413574 |
| 151 | MYB_26560356_Chip-Seq_TH1_Human | 0.93846301 |
| 152 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93352793 |
| 153 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93220846 |
| 154 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92923776 |
| 155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92558322 |
| 156 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91889334 |
| 157 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91821083 |
| 158 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91426876 |
| 159 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91197707 |
| 160 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90641251 |
| 161 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89844943 |
| 162 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89105629 |
| 163 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88985733 |
| 164 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88833902 |
| 165 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88405715 |
| 166 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88025527 |
| 167 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.87750156 |
| 168 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87568250 |
| 169 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87275141 |
| 170 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87082056 |
| 171 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86614365 |
| 172 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86185679 |
| 173 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85282569 |
| 174 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84807919 |
| 175 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84750701 |
| 176 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82991292 |
| 177 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80882443 |
| 178 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79308321 |
| 179 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78480761 |
| 180 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78208503 |
| 181 | MAF_26560356_Chip-Seq_TH2_Human | 0.77921047 |
| 182 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75749817 |
| 183 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75020186 |
| 184 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73694795 |
| 185 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73344041 |
| 186 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72005442 |
| 187 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.69580673 |
| 188 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68534470 |
| 189 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67730589 |
| 190 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67554475 |
| 191 | P300_27268052_Chip-Seq_Bcells_Human | 0.67076061 |
| 192 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66638280 |
| 193 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.65777063 |
| 194 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64995561 |
| 195 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.63228170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.40103283 |
| 2 | MP0006082_CNS_inflammation | 3.73502192 |
| 3 | MP0003436_decreased_susceptibility_to | 3.47179606 |
| 4 | MP0009785_altered_susceptibility_to | 3.38796082 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.37362203 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.27306440 |
| 7 | MP0005671_abnormal_response_to | 3.05306472 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.03296929 |
| 9 | MP0001790_abnormal_immune_system | 2.96052891 |
| 10 | MP0005387_immune_system_phenotype | 2.96052891 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.90936661 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.89377329 |
| 13 | MP0002102_abnormal_ear_morphology | 2.87990675 |
| 14 | MP0009840_abnormal_foam_cell | 2.73576409 |
| 15 | MP0002419_abnormal_innate_immunity | 2.70071871 |
| 16 | MP0004742_abnormal_vestibular_system | 2.68693469 |
| 17 | MP0001486_abnormal_startle_reflex | 2.65962862 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.65569392 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.64817351 |
| 20 | MP0005025_abnormal_response_to | 2.61606905 |
| 21 | MP0009379_abnormal_foot_pigmentation | 2.60995787 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.59167848 |
| 23 | MP0005409_darkened_coat_color | 2.58903984 |
| 24 | MP0004270_analgesia | 2.58320328 |
| 25 | MP0001188_hyperpigmentation | 2.57901864 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.55956144 |
| 27 | MP0002064_seizures | 2.49595415 |
| 28 | MP0009745_abnormal_behavioral_response | 2.43265465 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.41056914 |
| 30 | MP0002272_abnormal_nervous_system | 2.37602764 |
| 31 | MP0001440_abnormal_grooming_behavior | 2.32839485 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.32490603 |
| 33 | MP0001800_abnormal_humoral_immune | 2.27443087 |
| 34 | MP0009764_decreased_sensitivity_to | 2.26603772 |
| 35 | MP0002723_abnormal_immune_serum | 2.24448063 |
| 36 | MP0002452_abnormal_antigen_presenting | 2.23828410 |
| 37 | MP0001529_abnormal_vocalization | 2.18324224 |
| 38 | MP0002063_abnormal_learning/memory/cond | 2.17928048 |
| 39 | MP0003172_abnormal_lysosome_physiology | 2.17653708 |
| 40 | MP0002736_abnormal_nociception_after | 2.16027347 |
| 41 | MP0001485_abnormal_pinna_reflex | 2.12860356 |
| 42 | MP0001533_abnormal_skeleton_physiology | 2.10746021 |
| 43 | MP0000778_abnormal_nervous_system | 2.10204708 |
| 44 | MP0000685_abnormal_immune_system | 2.10006491 |
| 45 | MP0009046_muscle_twitch | 2.08349055 |
| 46 | MP0002067_abnormal_sensory_capabilities | 2.07967626 |
| 47 | MP0010155_abnormal_intestine_physiology | 2.06114318 |
| 48 | MP0002735_abnormal_chemical_nociception | 2.04101903 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.99210205 |
| 50 | MP0001905_abnormal_dopamine_level | 1.96639312 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.95962646 |
| 52 | MP0004510_myositis | 1.92919788 |
| 53 | MP0004142_abnormal_muscle_tone | 1.91666367 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.89131344 |
| 55 | MP0003878_abnormal_ear_physiology | 1.89131344 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.88094616 |
| 57 | MP0001819_abnormal_immune_cell | 1.87122757 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.86069530 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.84230670 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.84212982 |
| 61 | MP0000343_altered_response_to | 1.83192954 |
| 62 | MP0002822_catalepsy | 1.82979068 |
| 63 | MP0003195_calcinosis | 1.81689015 |
| 64 | MP0003136_yellow_coat_color | 1.80822175 |
| 65 | MP0000920_abnormal_myelination | 1.79272386 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.77366817 |
| 67 | MP0008469_abnormal_protein_level | 1.77265082 |
| 68 | MP0003075_altered_response_to | 1.76442375 |
| 69 | MP0000462_abnormal_digestive_system | 1.76163716 |
| 70 | MP0001970_abnormal_pain_threshold | 1.73674233 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.70190857 |
| 72 | MP0003879_abnormal_hair_cell | 1.67101434 |
| 73 | MP0000604_amyloidosis | 1.60996639 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.58723435 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.55795017 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.54400004 |
| 77 | MP0005381_digestive/alimentary_phenotyp | 1.52780090 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.52746965 |
| 79 | MP0002405_respiratory_system_inflammati | 1.52516742 |
| 80 | MP0004947_skin_inflammation | 1.50367478 |
| 81 | MP0001664_abnormal_digestion | 1.49795671 |
| 82 | MP0001663_abnormal_digestive_system | 1.49159030 |
| 83 | MP0009278_abnormal_bone_marrow | 1.48466493 |
| 84 | MP0001501_abnormal_sleep_pattern | 1.47426982 |
| 85 | MP0005365_abnormal_bile_salt | 1.46541674 |
| 86 | MP0001853_heart_inflammation | 1.44739584 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 1.43750416 |
| 88 | MP0003938_abnormal_ear_development | 1.38432620 |
| 89 | MP0008004_abnormal_stomach_pH | 1.36368070 |
| 90 | MP0000026_abnormal_inner_ear | 1.35870767 |
| 91 | MP0002184_abnormal_innervation | 1.35545810 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.32433208 |
| 93 | MP0005451_abnormal_body_composition | 1.31356932 |
| 94 | MP0002254_reproductive_system_inflammat | 1.29610514 |
| 95 | MP0005166_decreased_susceptibility_to | 1.29401626 |
| 96 | MP0000013_abnormal_adipose_tissue | 1.28913094 |
| 97 | MP0002998_abnormal_bone_remodeling | 1.27918050 |
| 98 | MP0002882_abnormal_neuron_morphology | 1.27911005 |
| 99 | MP0003183_abnormal_peptide_metabolism | 1.26340376 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 1.26297088 |
| 101 | MP0003315_abnormal_perineum_morphology | 1.25898362 |
| 102 | MP0000716_abnormal_immune_system | 1.25666465 |
| 103 | MP0002229_neurodegeneration | 1.24651688 |
| 104 | MP0003866_abnormal_defecation | 1.21517348 |
| 105 | MP0002066_abnormal_motor_capabilities/c | 1.20787154 |
| 106 | MP0005386_behavior/neurological_phenoty | 1.19991615 |
| 107 | MP0004924_abnormal_behavior | 1.19991615 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 1.16545559 |
| 109 | MP0001545_abnormal_hematopoietic_system | 1.16545559 |
| 110 | MP0002938_white_spotting | 1.15945875 |
| 111 | MP0006054_spinal_hemorrhage | 1.13406277 |
| 112 | MP0005464_abnormal_platelet_physiology | 1.09865122 |
| 113 | MP0000955_abnormal_spinal_cord | 1.08248438 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 1.07824073 |
| 115 | MP0003303_peritoneal_inflammation | 1.06003932 |
| 116 | MP0002752_abnormal_somatic_nervous | 1.04602051 |
| 117 | MP0000015_abnormal_ear_pigmentation | 1.03015459 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 1.02907038 |
| 119 | MP0006292_abnormal_olfactory_placode | 1.01871271 |
| 120 | MP0003448_altered_tumor_morphology | 1.00625779 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.98611227 |
| 122 | MP0000751_myopathy | 0.96561689 |
| 123 | MP0002751_abnormal_autonomic_nervous | 0.94857029 |
| 124 | MP0003385_abnormal_body_wall | 0.94804689 |
| 125 | MP0000566_synostosis | 0.93968430 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.90705084 |
| 127 | MP0002152_abnormal_brain_morphology | 0.90561253 |
| 128 | MP0002638_abnormal_pupillary_reflex | 0.90282574 |
| 129 | MP0002398_abnormal_bone_marrow | 0.90051224 |
| 130 | MP0004885_abnormal_endolymph | 0.89005227 |
| 131 | MP0008569_lethality_at_weaning | 0.88669960 |
| 132 | MP0005360_urolithiasis | 0.88622566 |
| 133 | MP0002429_abnormal_blood_cell | 0.87633073 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.87107441 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.87093836 |
| 136 | MP0006072_abnormal_retinal_apoptosis | 0.86255833 |
| 137 | MP0009763_increased_sensitivity_to | 0.86039091 |
| 138 | MP0003724_increased_susceptibility_to | 0.84585675 |
| 139 | MP0000858_altered_metastatic_potential | 0.82608857 |
| 140 | MP0005645_abnormal_hypothalamus_physiol | 0.82033109 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.81789602 |
| 142 | MP0002653_abnormal_ependyma_morphology | 0.81697907 |
| 143 | MP0005085_abnormal_gallbladder_physiolo | 0.81340121 |
| 144 | MP0004883_abnormal_blood_vessel | 0.81063441 |
| 145 | MP0003634_abnormal_glial_cell | 0.80835754 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.80601793 |
| 147 | MP0001666_abnormal_nutrient_absorption | 0.78930603 |
| 148 | MP0005390_skeleton_phenotype | 0.78738967 |
| 149 | MP0005164_abnormal_response_to | 0.78218973 |
| 150 | MP0001764_abnormal_homeostasis | 0.77352627 |
| 151 | MP0005171_absent_coat_pigmentation | 0.77185536 |
| 152 | MP0002722_abnormal_immune_system | 0.76731839 |
| 153 | MP0001986_abnormal_taste_sensitivity | 0.76507331 |
| 154 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76407991 |
| 155 | MP0002277_abnormal_respiratory_mucosa | 0.76076767 |
| 156 | MP0004381_abnormal_hair_follicle | 0.74909498 |
| 157 | MP0000467_abnormal_esophagus_morphology | 0.74529785 |
| 158 | MP0004145_abnormal_muscle_electrophysio | 0.74314799 |
| 159 | MP0009250_abnormal_appendicular_skeleto | 0.74239493 |
| 160 | MP0010386_abnormal_urinary_bladder | 0.73140645 |
| 161 | MP0003646_muscle_fatigue | 0.73082058 |
| 162 | MP0008874_decreased_physiological_sensi | 0.72956350 |
| 163 | MP0003329_amyloid_beta_deposits | 0.72954743 |
| 164 | MP0002069_abnormal_eating/drinking_beha | 0.72693310 |
| 165 | MP0005195_abnormal_posterior_eye | 0.71198747 |
| 166 | MP0002933_joint_inflammation | 0.70865027 |
| 167 | MP0002332_abnormal_exercise_endurance | 0.69904271 |
| 168 | MP0004147_increased_porphyrin_level | 0.69829868 |
| 169 | MP0005535_abnormal_body_temperature | 0.69553355 |
| 170 | MP0001873_stomach_inflammation | 0.68237442 |
| 171 | MP0003690_abnormal_glial_cell | 0.67985764 |
| 172 | MP0009765_abnormal_xenobiotic_induced | 0.66418841 |
| 173 | MP0005084_abnormal_gallbladder_morpholo | 0.65769298 |
| 174 | MP0003828_pulmonary_edema | 0.65305794 |
| 175 | MP0004811_abnormal_neuron_physiology | 0.63910025 |
| 176 | MP0005310_abnormal_salivary_gland | 0.63350067 |
| 177 | MP0000249_abnormal_blood_vessel | 0.63059974 |
| 178 | MP0000049_abnormal_middle_ear | 0.62453177 |
| 179 | MP0002693_abnormal_pancreas_physiology | 0.61294766 |
| 180 | MP0005647_abnormal_sex_gland | 0.60766468 |
| 181 | MP0000609_abnormal_liver_physiology | 0.60438705 |
| 182 | MP0009643_abnormal_urine_homeostasis | 0.60328441 |
| 183 | MP0002837_dystrophic_cardiac_calcinosis | 0.58420597 |
| 184 | MP0003656_abnormal_erythrocyte_physiolo | 0.56859208 |
| 185 | MP0002118_abnormal_lipid_homeostasis | 0.55393388 |
| 186 | MP0001851_eye_inflammation | 0.54314869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.01909108 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.01909108 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.01909108 |
| 4 | Optic neuritis (HP:0100653) | 5.02197466 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.02197466 |
| 6 | Orchitis (HP:0100796) | 5.00062996 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.85855079 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.81841200 |
| 9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.79692868 |
| 10 | Myositis (HP:0100614) | 4.68652658 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.60534829 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.44989125 |
| 13 | Stomatitis (HP:0010280) | 4.43920826 |
| 14 | Focal motor seizures (HP:0011153) | 4.39445674 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.37437112 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.37341500 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.30975111 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.90715772 |
| 19 | Mutism (HP:0002300) | 3.83013516 |
| 20 | Hyperthyroidism (HP:0000836) | 3.81297851 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.72843775 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.72843775 |
| 23 | Disinhibition (HP:0000734) | 3.70581205 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.68460270 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.67757167 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.65836774 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.65594390 |
| 28 | Loss of speech (HP:0002371) | 3.64217670 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.56436116 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.38285001 |
| 31 | Atonic seizures (HP:0010819) | 3.35421168 |
| 32 | Absent/shortened dynein arms (HP:0200106) | 3.34774496 |
| 33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.34774496 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.27289538 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24606979 |
| 36 | Bowel incontinence (HP:0002607) | 3.20570973 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.19828826 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.19828826 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.19828826 |
| 40 | Abnormal large intestine physiology (HP:0012700) | 3.18137184 |
| 41 | Malnutrition (HP:0004395) | 3.06025924 |
| 42 | Glomerulonephritis (HP:0000099) | 3.02168705 |
| 43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.02059177 |
| 44 | Epileptic encephalopathy (HP:0200134) | 3.01664590 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01254772 |
| 46 | Sensory axonal neuropathy (HP:0003390) | 2.98120456 |
| 47 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.96907223 |
| 48 | Hematochezia (HP:0002573) | 2.95132887 |
| 49 | Obstructive lung disease (HP:0006536) | 2.95030775 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95030775 |
| 51 | Fragile nails (HP:0001808) | 2.93072208 |
| 52 | Seborrheic dermatitis (HP:0001051) | 2.92442930 |
| 53 | Abnormal ciliary motility (HP:0012262) | 2.91976451 |
| 54 | Encephalitis (HP:0002383) | 2.91789533 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90925210 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.90925210 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.90910564 |
| 58 | Broad-based gait (HP:0002136) | 2.90858515 |
| 59 | Febrile seizures (HP:0002373) | 2.90736158 |
| 60 | Vasculitis (HP:0002633) | 2.89968957 |
| 61 | Neurofibrillary tangles (HP:0002185) | 2.88099629 |
| 62 | Concave nail (HP:0001598) | 2.87760674 |
| 63 | Hyperventilation (HP:0002883) | 2.85537005 |
| 64 | Hemoptysis (HP:0002105) | 2.85330744 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.84801705 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.79753497 |
| 67 | Focal seizures (HP:0007359) | 2.73753141 |
| 68 | Parakeratosis (HP:0001036) | 2.71094818 |
| 69 | Esotropia (HP:0000565) | 2.67251930 |
| 70 | Mitochondrial inheritance (HP:0001427) | 2.66797714 |
| 71 | Recurrent skin infections (HP:0001581) | 2.64829768 |
| 72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.63882883 |
| 73 | Thickened helices (HP:0000391) | 2.62479953 |
| 74 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.58930690 |
| 75 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.58930690 |
| 76 | Metaphyseal irregularity (HP:0003025) | 2.58257206 |
| 77 | Amyloidosis (HP:0011034) | 2.58022683 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.55224532 |
| 79 | Amblyopia (HP:0000646) | 2.54701206 |
| 80 | Atelectasis (HP:0100750) | 2.54697163 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.54537376 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.52690627 |
| 83 | Increased IgM level (HP:0003496) | 2.50448128 |
| 84 | Meningitis (HP:0001287) | 2.48095700 |
| 85 | Gangrene (HP:0100758) | 2.47515829 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.47429466 |
| 87 | Entropion (HP:0000621) | 2.42957091 |
| 88 | Polyphagia (HP:0002591) | 2.42082773 |
| 89 | Abnormality of renal resorption (HP:0011038) | 2.40927862 |
| 90 | Overfolded helix (HP:0000396) | 2.40656111 |
| 91 | Abnormality of DNA repair (HP:0003254) | 2.39841755 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.39376406 |
| 93 | Absence seizures (HP:0002121) | 2.38776908 |
| 94 | Cone-rod dystrophy (HP:0000548) | 2.38651694 |
| 95 | Limb dystonia (HP:0002451) | 2.37868095 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37573150 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37276258 |
| 98 | Increased serum ferritin (HP:0003281) | 2.36719080 |
| 99 | Dialeptic seizures (HP:0011146) | 2.36587174 |
| 100 | Optic disc pallor (HP:0000543) | 2.35452148 |
| 101 | Hypertensive crisis (HP:0100735) | 2.34534277 |
| 102 | Nausea (HP:0002018) | 2.33924481 |
| 103 | Lipid accumulation in hepatocytes (HP:0006561) | 2.33894696 |
| 104 | Anorexia (HP:0002039) | 2.29528515 |
| 105 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.28546720 |
| 106 | Absent speech (HP:0001344) | 2.26932000 |
| 107 | Petechiae (HP:0000967) | 2.25381701 |
| 108 | Polyneuropathy (HP:0001271) | 2.25250690 |
| 109 | Abnormally folded helix (HP:0008544) | 2.24479247 |
| 110 | Truncus arteriosus (HP:0001660) | 2.24137300 |
| 111 | Gingivitis (HP:0000230) | 2.22596277 |
| 112 | Failure to thrive in infancy (HP:0001531) | 2.17547916 |
| 113 | Purpura (HP:0000979) | 2.15986945 |
| 114 | Poikiloderma (HP:0001029) | 2.15597650 |
| 115 | Erythroderma (HP:0001019) | 2.13026399 |
| 116 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.12791365 |
| 117 | Abnormality of the pleura (HP:0002103) | 2.11620340 |
| 118 | Joint swelling (HP:0001386) | 2.10152368 |
| 119 | Hepatocellular necrosis (HP:0001404) | 2.09854891 |
| 120 | Visual hallucinations (HP:0002367) | 2.09369019 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.09021187 |
| 122 | Inappropriate behavior (HP:0000719) | 2.07342273 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 2.06996589 |
| 124 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06475545 |
| 125 | Flat occiput (HP:0005469) | 2.06219687 |
| 126 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04995414 |
| 127 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04995414 |
| 128 | Abnormality of the parathyroid morphology (HP:0011766) | 2.04986469 |
| 129 | Urticaria (HP:0001025) | 2.04293141 |
| 130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02034715 |
| 131 | Abnormality of the tricuspid valve (HP:0001702) | 2.01700908 |
| 132 | Nuclear cataract (HP:0100018) | 2.01484216 |
| 133 | Retinal dysplasia (HP:0007973) | 2.00945157 |
| 134 | Axonal loss (HP:0003447) | 2.00757734 |
| 135 | Arterial thrombosis (HP:0004420) | 1.99930134 |
| 136 | Deep palmar crease (HP:0006191) | 1.99666270 |
| 137 | Episodic fever (HP:0001954) | 1.99509990 |
| 138 | Pulmonary embolism (HP:0002204) | 1.99419155 |
| 139 | Akinesia (HP:0002304) | 1.98737133 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98168037 |
| 141 | Exotropia (HP:0000577) | 1.98138045 |
| 142 | Hypoparathyroidism (HP:0000829) | 1.96692579 |
| 143 | Leukocytosis (HP:0001974) | 1.96547772 |
| 144 | Recurrent viral infections (HP:0004429) | 1.96542037 |
| 145 | Agnosia (HP:0010524) | 1.96127702 |
| 146 | Chronic diarrhea (HP:0002028) | 1.94935474 |
| 147 | Abnormality of T cell number (HP:0011839) | 1.93926638 |
| 148 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93140417 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.93035050 |
| 150 | Insidious onset (HP:0003587) | 1.92620892 |
| 151 | Termporal pattern (HP:0011008) | 1.92620892 |
| 152 | Hypophosphatemic rickets (HP:0004912) | 1.92569933 |
| 153 | Abnormality of the axillary hair (HP:0100134) | 1.90662667 |
| 154 | Abnormality of secondary sexual hair (HP:0009888) | 1.90662667 |
| 155 | Complement deficiency (HP:0004431) | 1.90631039 |
| 156 | Asthma (HP:0002099) | 1.90414176 |
| 157 | Acute encephalopathy (HP:0006846) | 1.90279133 |
| 158 | Neuronal loss in central nervous system (HP:0002529) | 1.90128534 |
| 159 | Widely patent fontanelles and sutures (HP:0004492) | 1.89870007 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.89686083 |
| 161 | Recurrent pneumonia (HP:0006532) | 1.89384453 |
| 162 | Acne (HP:0001061) | 1.88297465 |
| 163 | Vertigo (HP:0002321) | 1.88030835 |
| 164 | Clumsiness (HP:0002312) | 1.87827440 |
| 165 | T lymphocytopenia (HP:0005403) | 1.87372730 |
| 166 | Hyperphosphaturia (HP:0003109) | 1.86965889 |
| 167 | Congenital malformation of the right heart (HP:0011723) | 1.86896899 |
| 168 | Double outlet right ventricle (HP:0001719) | 1.86896899 |
| 169 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86174186 |
| 170 | Partial agenesis of the corpus callosum (HP:0001338) | 1.85847953 |
| 171 | Memory impairment (HP:0002354) | 1.85649612 |
| 172 | Glycosuria (HP:0003076) | 1.84024853 |
| 173 | Abnormality of urine glucose concentration (HP:0011016) | 1.84024853 |
| 174 | Pustule (HP:0200039) | 1.83909086 |
| 175 | Abnormal eating behavior (HP:0100738) | 1.83634170 |
| 176 | Exertional dyspnea (HP:0002875) | 1.83599731 |
| 177 | Alacrima (HP:0000522) | 1.83570410 |
| 178 | Progressive cerebellar ataxia (HP:0002073) | 1.83516286 |
| 179 | Increased CSF lactate (HP:0002490) | 1.82957579 |
| 180 | Hypergammaglobulinemia (HP:0010702) | 1.82144428 |
| 181 | Abnormality of lateral ventricle (HP:0030047) | 1.81583051 |
| 182 | Basal ganglia calcification (HP:0002135) | 1.81554761 |
| 183 | Dysmetria (HP:0001310) | 1.81050336 |
| 184 | Supranuclear gaze palsy (HP:0000605) | 1.80293033 |
| 185 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79987481 |
| 186 | Abnormality of the septum pellucidum (HP:0007375) | 1.79087471 |
| 187 | Anomalous pulmonary venous return (HP:0010772) | 1.78564736 |
| 188 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78377325 |
| 189 | Keratitis (HP:0000491) | 1.78362022 |
| 190 | Diminished motivation (HP:0000745) | 1.78049522 |
| 191 | Nasolacrimal duct obstruction (HP:0000579) | 1.77945881 |
| 192 | Decreased lacrimation (HP:0000633) | 1.77485561 |
| 193 | Protruding tongue (HP:0010808) | 1.76668808 |
| 194 | Abnormality of the pericardium (HP:0001697) | 1.75982270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.64153047 |
| 2 | TLK1 | 4.64131242 |
| 3 | TNIK | 3.89732155 |
| 4 | ACVR1B | 3.31827826 |
| 5 | MAPK15 | 3.17511222 |
| 6 | IRAK3 | 3.13662173 |
| 7 | BLK | 3.10331751 |
| 8 | TYK2 | 2.80020272 |
| 9 | MAP4K1 | 2.74401906 |
| 10 | FES | 2.70818523 |
| 11 | MAP3K11 | 2.66143701 |
| 12 | MKNK2 | 2.52867951 |
| 13 | ADRBK2 | 2.48884039 |
| 14 | NME1 | 2.48216790 |
| 15 | MST1R | 2.46327780 |
| 16 | TBK1 | 2.44364803 |
| 17 | RIPK4 | 2.42216065 |
| 18 | MATK | 2.39145542 |
| 19 | TXK | 2.36281522 |
| 20 | MAP3K14 | 2.32826486 |
| 21 | ERN1 | 2.30023573 |
| 22 | CDK19 | 2.27494656 |
| 23 | NTRK3 | 2.10120847 |
| 24 | PNCK | 2.09041235 |
| 25 | IKBKE | 2.08969392 |
| 26 | IKBKB | 2.04950835 |
| 27 | IRAK2 | 2.01505488 |
| 28 | MAP3K12 | 2.00558085 |
| 29 | EPHA4 | 1.98686932 |
| 30 | TAOK2 | 1.98120935 |
| 31 | STK16 | 1.98069737 |
| 32 | OXSR1 | 1.90938447 |
| 33 | TGFBR2 | 1.89835452 |
| 34 | STK39 | 1.82705632 |
| 35 | DDR2 | 1.74674912 |
| 36 | TAOK1 | 1.71910522 |
| 37 | PIK3CA | 1.63675432 |
| 38 | MARK1 | 1.60115004 |
| 39 | MAPK13 | 1.52411810 |
| 40 | SYK | 1.51870169 |
| 41 | JAK3 | 1.49361566 |
| 42 | FGR | 1.48863628 |
| 43 | PRPF4B | 1.47467256 |
| 44 | CSF1R | 1.43667774 |
| 45 | MAP3K3 | 1.40706364 |
| 46 | UHMK1 | 1.38921350 |
| 47 | MST4 | 1.32776558 |
| 48 | RIPK1 | 1.31374106 |
| 49 | KIT | 1.30226043 |
| 50 | MAP2K7 | 1.29653739 |
| 51 | MAP2K2 | 1.28115728 |
| 52 | ZAP70 | 1.27482567 |
| 53 | PKN1 | 1.26276966 |
| 54 | BMPR1B | 1.24530380 |
| 55 | CAMK2B | 1.23045575 |
| 56 | MAP2K3 | 1.22577418 |
| 57 | SIK2 | 1.20369277 |
| 58 | NME2 | 1.17510387 |
| 59 | CDC42BPA | 1.16054706 |
| 60 | BRAF | 1.15462168 |
| 61 | JAK1 | 1.10313010 |
| 62 | MKNK1 | 1.08348381 |
| 63 | LCK | 1.06684135 |
| 64 | YES1 | 1.03891921 |
| 65 | MAP2K6 | 1.03730371 |
| 66 | TAOK3 | 1.01746993 |
| 67 | JAK2 | 1.00287216 |
| 68 | KSR2 | 1.00194511 |
| 69 | BTK | 1.00124653 |
| 70 | PIM2 | 0.99040648 |
| 71 | MOS | 0.98929035 |
| 72 | MAP3K1 | 0.97038793 |
| 73 | CDK5 | 0.92949974 |
| 74 | NTRK2 | 0.92797508 |
| 75 | CAMK2D | 0.91479212 |
| 76 | DAPK2 | 0.90814645 |
| 77 | ROCK2 | 0.90482626 |
| 78 | ABL2 | 0.88733707 |
| 79 | CAMKK2 | 0.86440480 |
| 80 | CHUK | 0.86134060 |
| 81 | CAMK2A | 0.84969780 |
| 82 | MAP3K9 | 0.83383434 |
| 83 | GRK6 | 0.82316172 |
| 84 | HCK | 0.80605754 |
| 85 | LIMK1 | 0.80470098 |
| 86 | FRK | 0.80221429 |
| 87 | MINK1 | 0.79574798 |
| 88 | MAP3K4 | 0.78013810 |
| 89 | PAK6 | 0.76121225 |
| 90 | IRAK1 | 0.75818774 |
| 91 | EPHB1 | 0.74959330 |
| 92 | STK11 | 0.74861755 |
| 93 | MARK3 | 0.74715304 |
| 94 | DYRK1A | 0.72697778 |
| 95 | TNK2 | 0.72376399 |
| 96 | BMPR2 | 0.72020421 |
| 97 | MET | 0.70682738 |
| 98 | CAMK1G | 0.69311363 |
| 99 | MAP3K5 | 0.69306939 |
| 100 | AKT3 | 0.65452450 |
| 101 | RAF1 | 0.63839534 |
| 102 | TGFBR1 | 0.62657957 |
| 103 | GRK1 | 0.60328159 |
| 104 | PDK1 | 0.58807561 |
| 105 | IRAK4 | 0.58793635 |
| 106 | CDK8 | 0.57933600 |
| 107 | DMPK | 0.57920413 |
| 108 | TEC | 0.54847623 |
| 109 | FYN | 0.54844576 |
| 110 | CLK1 | 0.53718569 |
| 111 | DYRK2 | 0.53589815 |
| 112 | PRKG2 | 0.53410188 |
| 113 | GRK5 | 0.53274874 |
| 114 | MAP2K4 | 0.53065368 |
| 115 | CDK14 | 0.52444510 |
| 116 | CSNK1G3 | 0.50786913 |
| 117 | WNK4 | 0.50035148 |
| 118 | EPHA3 | 0.49795230 |
| 119 | PIM1 | 0.49541512 |
| 120 | MAP3K2 | 0.49092575 |
| 121 | PTK2B | 0.48695079 |
| 122 | ITK | 0.48257016 |
| 123 | NEK6 | 0.47290154 |
| 124 | ABL1 | 0.47146107 |
| 125 | PLK2 | 0.46680980 |
| 126 | PDPK1 | 0.46285494 |
| 127 | CSK | 0.45841934 |
| 128 | DAPK3 | 0.44216590 |
| 129 | MAP3K6 | 0.43728302 |
| 130 | CSNK1G2 | 0.43191061 |
| 131 | PRKCE | 0.43177152 |
| 132 | CDK15 | 0.42647382 |
| 133 | PRKCQ | 0.42475734 |
| 134 | CDK11A | 0.41893383 |
| 135 | EPHB2 | 0.41208849 |
| 136 | PRKCG | 0.40755536 |
| 137 | CDK18 | 0.39938693 |
| 138 | NTRK1 | 0.39539267 |
| 139 | RPS6KA6 | 0.39418208 |
| 140 | CAMK2G | 0.37909449 |
| 141 | LYN | 0.37807464 |
| 142 | BCKDK | 0.37600717 |
| 143 | GRK7 | 0.37591251 |
| 144 | ADRBK1 | 0.37260787 |
| 145 | PRKCZ | 0.36578957 |
| 146 | RPS6KL1 | 0.35111492 |
| 147 | RPS6KC1 | 0.35111492 |
| 148 | SIK3 | 0.34656171 |
| 149 | PRKG1 | 0.34630011 |
| 150 | STK10 | 0.34610998 |
| 151 | TYRO3 | 0.34385308 |
| 152 | PRKD2 | 0.34298303 |
| 153 | TESK2 | 0.32403626 |
| 154 | KSR1 | 0.31687052 |
| 155 | CSNK1G1 | 0.31685405 |
| 156 | MARK2 | 0.31521738 |
| 157 | PRKCD | 0.31295907 |
| 158 | MAP3K13 | 0.30729194 |
| 159 | BCR | 0.29567070 |
| 160 | RPS6KA2 | 0.29504405 |
| 161 | GSK3A | 0.26799123 |
| 162 | PRKACG | 0.25106028 |
| 163 | CAMK1D | 0.24217091 |
| 164 | MAPK4 | 0.21915831 |
| 165 | INSR | 0.20767689 |
| 166 | FGFR3 | 0.20421277 |
| 167 | MAPKAPK2 | 0.20336551 |
| 168 | PRKAA2 | 0.20188038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.54529852 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.43906720 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02120492 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.99945799 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.85013787 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73131622 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70947774 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66556597 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.57597824 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57107106 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54969178 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43401798 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.41357422 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38100540 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28427390 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 2.28040438 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 2.25222041 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.20534942 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.17173501 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.16679031 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.13485922 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13122881 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.04062109 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 2.02054419 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01405008 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.97750818 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.92624040 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.86262950 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.85161355 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.83824195 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.81628567 |
| 32 | Morphine addiction_Homo sapiens_hsa05032 | 1.81520807 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77941431 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.76820094 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.75020758 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74036754 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.72234323 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71791585 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.67912698 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.62888355 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.61507321 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58649839 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56667080 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53457668 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50222504 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49508348 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.49310499 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.48800090 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48535828 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.47440961 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46843519 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44403401 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42785888 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.42477435 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.41783336 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.39393423 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38150638 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35350594 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34833542 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34747967 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.34078437 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30945709 |
| 63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.30659012 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30077974 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26732346 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25899688 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22835998 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22328338 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 1.21587153 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 1.20913090 |
| 71 | Ribosome_Homo sapiens_hsa03010 | 1.19429717 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14556840 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09106732 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09022358 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08008231 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06715141 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05092054 |
| 78 | Measles_Homo sapiens_hsa05162 | 1.01332783 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00764145 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99523574 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94008570 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89578794 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88237168 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87998102 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.86764166 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86195267 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85760903 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84991509 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84885887 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84141529 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81261485 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.80489748 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.80031559 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77793029 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77575262 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76107346 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74074355 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73256722 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72667173 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71706744 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70252420 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69614171 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69584095 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66122356 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65254181 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64101541 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63590466 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63236259 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.61964699 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61330461 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60744270 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.60317979 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60289779 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.60118990 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60030460 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.59754227 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59485408 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59264830 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59057446 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58516963 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57217187 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56195181 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.55260506 |
| 124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54158401 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53915686 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53469206 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.52456325 |
| 128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51141600 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48835750 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46990853 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46489593 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.45666571 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45616161 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45221036 |
| 135 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43505870 |
| 136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41907262 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41058134 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40741472 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40328039 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.38886181 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38253358 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.38059549 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37632041 |
| 144 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36539926 |
| 145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35995002 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.35893212 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34933888 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34800894 |
| 149 | Asthma_Homo sapiens_hsa05310 | 0.34192916 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34026895 |
| 151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33066175 |
| 152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32988363 |
| 153 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.32672010 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32245405 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31842293 |
| 156 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30160890 |
| 157 | Homologous recombination_Homo sapiens_hsa03440 | 0.29588423 |
| 158 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28145318 |
| 159 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27756456 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | 0.26108725 |
| 161 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26056960 |
| 162 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24454845 |
| 163 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23643591 |
| 164 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21824721 |
| 165 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21629276 |
| 166 | ABC transporters_Homo sapiens_hsa02010 | 0.21546806 |
| 167 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21221468 |
| 168 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20323511 |
| 169 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.17651462 |
| 170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15937515 |

